AIChE and the Society for Biological Engineering (SBE) have launched with publishing partner Wiley the new open-access journal Bioengineering & Translational Medicine, whose first issue is now available.
This new journal focuses on ways chemical and biological engineering drive innovations and solutions that impact clinical practice and commercial healthcare products. The journal also highlights scientific and technical breakthroughs currently in the process of clinical and commercial translation. The first issue focuses on Nanoparticles in Medicine, which you can read more about in the issue’s introduction.
The entire publication is open access so all current articles can be read online here.
As new articles are accepted they will be posted online. You can follow newly accepted articles here in anticipation of the second issue.